All episodes
AI Drug Discovery: Who Owns the IP Rights?
Multi-State Non-Competes: The Site Network Template Trap
100% HIPAA Compliant"? Why Your Badges Are Legal Debt
Decoding 340B: History, Legislative Styles, and Healthcare Policy with Deborah Williams
Contrast Therapy: The Hidden Legal & Water Risks
BPC-157: The FDA Blacklist, PCAC Vote & Legal Exposure
FDA Under Pressure: Enforcement, DOGE & Global Supply Chains
Health Tech Startups: From Garage to FDA
Is Your Clinical Trial IP Already Leaked?
Decoding Australia's TGA Regulations
AI "Going Rogue": The Legality of Healthcare Chatbots
Pharmacy's Critical Role in Clinical Trial Compliance
The Wild Lizard Venom Origins of Ozempic
Unlicensed Medical Advice & The Legal Battle Over Character.AI
Sponsoring Cannabis Research
The New Era of Personal Consent Decrees
Why Private Membership Associations Fail FDA Scrutiny
The Hidden Reason Sites are Firing Recruiters
Don’t Let Your PI Walk Away With Your Study
Safe or Just "Not Dirty"? The Regulatory Gamble of Compounded Drugs
"Basically Employees" Isn't a Legal Category (And the OIG Knows It)
The Hidden Legal Risks of AI Sponsor Protocols
The $100M Mistake: Why AI-Generated Drugs May Not Be Patentable
Is AI replacing your Doctor?
Why the OIG Just Revolutionized Pharma Marketing (And What It Costs You)
6 Categories of "Bulk Data" That Could Land You in Federal Court.
The Utah Experiment: The Dangerous New Frontier of AI Prescribing
Is Your DTC Program a Kickback Trap?
The Hidden Death Sentence for Trial Sites
FDA "Screams": The Real Reason Your Snack Is At Risk
2 Laws More Dangerous Than HIPAA for Patient Engagement
"Invite-Only" Compliance Is Over: Is Your Cosmetic Company Ready?
Audit-Proof Your Site: The Training Gap Killing Your Contracts
15 Years in Prison for Marketing Fraud
Is your "Clinical Decision Support" tool actually an unregulated medical device?
The FDA’s New Political Enforcement Strategy
Why Your "Physician-Only" Ads Aren't Safe from Regulators
The Messy Reality of AI Prescriptions
Why Your Consultant’s Report Is a Legal Liability
Stop Reporting Results? The NIH’s "Get Out of Jail Free" Card
Final LGBTQ Individuals in clinical research
When the FDA Plays Politics
Your Site’s Background Check is Illegally Incomplete - Here is why
Is Your Off-Label Use Now a Federal Crime?
10,000 Specialists: A Futurist’s Vision for AI Healthcare
The Battle Over Weight Loss and Compounded Drugs
Why Cosmetic Ingredient Names Matter and What MOCRA Really Means - Interview with Heather Bustos
Compliance Isn’t a Deal Killer… Until It Is - Interview with Stephanie Trunk
Cosmetic ingredients the FDA doesn’t want you to use
Why Federal Agencies Are Targeting Executives
Why the New Food Pyramid Matters to You
Ex FDA Commissioner Robert Califf on FDA Authority, Politics, and the Health Crisis No One Wants to Name
Buying a Med Spa? GLP-1 Compliance Can Kill the Deal
New crown jewel valuing patient data
Your Staff is trained, but can you prove it?
What Happens When a Sponsor Walks Away Early?
Cosmetic Claims the FDA Hates
Biggest Legal Mistakes in Influencer Marketing
Your Mood, Energy, and Sleep Claims Might Be Regulated
Device Fail: The Legal Anatomy of a Faulty Implant Scandal
5 Documents the FDA Will Demand on Site — Are You Ready?
Cosmetic Marketing Mistakes That Trigger Regulators
Why Your Clinical Trial Contract Is Leaving Cash on the Table
Why Testimonials Can Get Your Brand Sued
How to Get Sponsors to Pay Faster than Net 90
Compliance Mistakes That Kill Pharma and Biotech Deals
Balance FDA Rules with FTC Advertising Requirements
Key Clauses in PI Contracts to Review
Compliance guru talks practical Insights on Speaker Programs
Trends in Small Life Sciences Transactions
Protect Your Site If a Sponsor Terminates Early
Are Pharma Chatbots Putting You at Regulatory Risk?
Are Your Cosmetic Company Records Ready for FDA Audits?
When Medical Affairs Becomes Commercial in Disguise
Serious Adverse Event Reporting Under MoCRA
Key SOPs for Clinical Trials
Payer Presentations Can Trigger Enforcement
Pharmacies v manufacturers
Is Clinical Research Ready for the new FDA?
Is your cosmetics company FDA-registered?
Will AI Replace Doctors in clinical research?
Risks in Direct-to-Patient Engagement
Inside 340B: Challenges, Controversies, and Opportunities
IRBs in 2025: What’s Really Changing?
3 Red Flags in Telemedicine Partnerships
What do PBMs do?
How AMCs Build Stronger Compliance Cultures Together
How One DME Scheme Cost Medicare $61 Million
FDA to Step Up Enforcement on Pharma Advertising
Top 5 Factors Determining AMC Funding
New Series Drop: Exploring AMCs in Clinical Research
Why Choose a Licensed Attorney Over a Consultant?
Marketing Problems by Hims & Hers and Lilly
Should Sponsors Share Site Feedback?
AI Marketing Playbook for Drug Companies
Should Sites Be Ready on Standby?
Eastern District of PA Targets Pharmacies
Telehealth Done Right
DOJ and HHS Launch FCA Fraud Task Force
Should Sponsors Cover Malpractice Insurance?